Page last updated: 2024-10-24

chlorambucil and Acquired Immune Deficiency Syndrome

chlorambucil has been researched along with Acquired Immune Deficiency Syndrome in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research Excerpts

ExcerptRelevanceReference
"Pneumocystis carinii pneumonia is today an opportunistic infection of major importance, occurring in immunosuppressed patients."1.27Pneumocystis carinii pneumonia in Johannesburg. ( Abramowitz, JA; Hurwitz, MD; Kallenbach, JM; Pincus, PS; Zwi, S, 1987)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pincus, PS1
Hurwitz, MD1
Kallenbach, JM1
Abramowitz, JA1
Zwi, S1

Other Studies

1 other study available for chlorambucil and Acquired Immune Deficiency Syndrome

ArticleYear
Pneumocystis carinii pneumonia in Johannesburg.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1987, Mar-07, Volume: 71, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Chlorambucil; Female; Humans; Immunologic Def

1987